Pharmaceutical Executive March 27, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

The State of the Opioid Epidemic

In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.

Low Melatonin in the Gut Can Increase Risk of Neurological Disorders

Melatonin is linked to circadian rhythm, mitochondrial function, and neuroinflammation.

Patients Hate ‘Forever’ Drugs. Is Wegovy Different?

The new obesity drugs might be an exception to a chronic, deadly problem: the failure to stick with medication.

Virtual Second Opinions Save Over $8,700 Per Patient, New Analysis Finds

Third-party research...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals
Scientists reveal new method that could reduce waste from drug manufacturing

Share This Article